News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
498,764 Results
Type
Article (9547)
Company Profile (142)
Press Release (489095)
Multimedia
Podcasts (6)
Webinars (8)
Section
Business (170510)
Career Advice (538)
Deals (26325)
Drug Delivery (17)
Drug Development (55088)
Employer Resources (32)
FDA (10206)
Job Trends (9084)
News (244974)
Policy (18733)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (600)
Accelerated approval (24)
ADA (18)
Adcomms (2)
Allergies (103)
Alliances (34194)
ALS (113)
Alzheimer's disease (1011)
Antibody-drug conjugate (ADC) (277)
Approvals (10792)
Artificial intelligence (362)
ASCO (169)
Autoimmune disease (214)
Automation (31)
Bankruptcy (268)
Best Places to Work (7400)
BIO (38)
BIOSECURE Act (3)
Biosimilars (120)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (521)
Cancer (3797)
Cardiovascular disease (251)
Career advice (451)
Career pathing (12)
CAR-T (181)
CDC (1)
Celiac Disease (1)
Cell therapy (507)
Cervical cancer (35)
Clinical research (49637)
Collaboration (1283)
Commercialization (1)
Compensation (1399)
Complete response letters (39)
COVID-19 (890)
CRISPR (66)
C-suite (742)
Cystic fibrosis (84)
Data (5830)
Denatured (5)
Depression (105)
Dermatology (66)
Diabetes (362)
Diagnostics (4390)
Digital health (44)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (165)
Drug pricing (16)
Drug shortages (5)
Duchenne muscular dystrophy (165)
Earnings (74361)
Editorial (3)
Employer branding (3)
Employer resources (27)
Events (89696)
Executive appointments (702)
FDA (12884)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (24)
Funding (949)
Gene editing (131)
Generative AI (16)
Gene therapy (326)
GLP-1 (335)
Government (1144)
Grass and pollen (2)
Guidances (295)
Healthcare (10023)
Hematology (101)
HIV (55)
Huntington's disease (23)
IgA nephropathy (62)
Immunology and inflammation (112)
Immuno-oncology (60)
Indications (166)
Infectious disease (1084)
Inflammatory bowel disease (140)
Inflation Reduction Act (6)
Influenza (84)
Intellectual property (254)
Interviews (85)
IPO (12646)
IRA (4)
Job creations (2035)
Job search strategy (396)
JPM (5)
Kidney cancer (16)
Labor market (8)
Layoffs (84)
Leadership (9)
Legal (5312)
Licensing (1)
Liver cancer (47)
Longevity (19)
Lung cancer (518)
Lymphoma (267)
Machine learning (32)
Management (10)
Manufacturing (569)
Marketing (7)
MASH (121)
Medical device (9060)
Medtech (9195)
Mergers & acquisitions (14703)
Metabolic disorders (754)
mRNA (56)
Multiple sclerosis (108)
NASH (6)
Neurodegenerative disease (229)
Neuropsychiatric disorders (42)
Neuroscience (1880)
NextGen: Class of 2026 (3407)
Non-profit (1032)
Now hiring (3)
Obesity (248)
Opinion (48)
Ovarian cancer (162)
Pain (173)
Pancreatic cancer (195)
Parkinson's disease (202)
Partnered (16)
Patents (472)
Patient recruitment (504)
Peanut (34)
People (41973)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15945)
Phase 2 (22151)
Phase 3 (15191)
Pipeline (7079)
Policy (36)
Postmarket research (1639)
Preclinical (6763)
Press Release (40)
Prostate cancer (206)
Psychedelics (8)
Radiopharmaceuticals (193)
Rare diseases (590)
Real estate (3126)
Recruiting (17)
Regulatory (15428)
Reports (17)
Research institute (685)
Resumes & cover letters (78)
Rett syndrome (41)
RNA editing (10)
RSV (48)
Schizophrenia (102)
Series A (161)
Series B (128)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (13)
Startups (2096)
Stomach cancer (3)
Supply chain (61)
Tariffs (6)
The Weekly (1)
Vaccines (344)
Venture capital (19)
Weight loss (88)
Women's health (84)
Worklife (8)
Date
Today (85)
Last 7 days (319)
Last 30 days (1227)
Last 365 days (19903)
2026 (11477)
2025 (20110)
2024 (23909)
2023 (27539)
2022 (35640)
2021 (38369)
2020 (34979)
2019 (24860)
2018 (18497)
2017 (19509)
2016 (18594)
2015 (24991)
2014 (22213)
2013 (18522)
2012 (20651)
2011 (20906)
2010 (20750)
Location
Africa (269)
Alabama (73)
Alaska (3)
Arizona (295)
Arkansas (11)
Asia (19239)
Australia (2366)
California (11758)
Canada (3147)
China (589)
Colorado (498)
Connecticut (418)
Delaware (212)
Europe (28814)
Florida (1758)
Georgia (374)
Hawaii (3)
Idaho (47)
Illinois (714)
India (47)
Indiana (339)
Iowa (14)
Japan (399)
Kansas (101)
Kentucky (35)
Louisiana (30)
Maine (25)
Maryland (1221)
Massachusetts (7819)
Michigan (306)
Minnesota (559)
Mississippi (5)
Missouri (80)
Montana (20)
Nebraska (12)
Nevada (116)
New Hampshire (60)
New Jersey (2675)
New Mexico (12)
New York (2829)
North Carolina (1312)
North Dakota (4)
Northern California (5863)
Ohio (275)
Oklahoma (14)
Oregon (19)
Pennsylvania (2233)
Puerto Rico (20)
Rhode Island (30)
South America (467)
South Carolina (76)
South Dakota (1)
Southern California (4871)
Tennessee (122)
Texas (1893)
United States (38667)
Utah (352)
Vermont (1)
Virginia (153)
Washington D.C. (39)
Washington State (913)
West Virginia (2)
Wisconsin (76)
Wyoming (1)
498,764 Results for "pro dex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
April 30, 2026
·
10 min read
Business
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023.
November 2, 2023
·
6 min read
Press Releases
Pro-Lab Diagnostics Launches Pro-Cult® in the US — The Only QC Organism Line Manufactured Exclusively from NCTC® and NCPF® Source Strains
June 2, 2026
·
1 min read
Business
Pro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month Results
PRO-DEX, INC. announced financial results for its fiscal 2023 third quarter ended March 31, 2023.
May 4, 2023
·
8 min read
Press Releases
Prolium Bioscience Announces First Patient Dosed in its Multinational, Phase 1/2 Study of PRO-203 in Systemic Sclerosis, and Last Patient, Last Visit in an Investigator-Led Study of PRO-203 in Refractory Lupus Nephritis
June 22, 2026
·
3 min read
Press Releases
Sky Labs Showcases ‘CART BP pro’ for Potential Use in Drug Clinical Trials on Global Stage
July 3, 2026
·
4 min read
Business
Pro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month Results
PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 second quarter ended December 31, 2022.
February 2, 2023
·
6 min read
Press Releases
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
September 6, 2024
·
9 min read
Press Releases
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
June 11, 2026
·
5 min read
Press Releases
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
May 14, 2026
·
4 min read
1 of 49,877
Next
